Clearance of Blood-Borne Arboviruses
血源性虫媒病毒的清除
基本信息
- 批准号:10316169
- 负责人:
- 金额:$ 46.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-21 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AlphavirusAmino AcidsAntibodiesArbovirus InfectionsArbovirusesArginineBindingBiochemicalBiological AssayBloodBlood CirculationCellsChikungunya virusCollectionComplementDataDevelopmentDiseaseDistalEnzyme-Linked Immunosorbent AssayFlavivirusGeographyGlycoproteinsGoalsHumanImmunoglobulin GImmunoglobulin MImmunohistochemistryIn Situ HybridizationIndividualIntegration Host FactorsKnockout MiceKnowledgeKupffer CellsLicensingLigandsLiverLysineMass Spectrum AnalysisMediatingMusMutationMutation AnalysisOrthobunyavirusPathogenesisPathogenicityPathway interactionsPhagocytesPopulationPositioning AttributePost-Translational Protein ProcessingProteinsProteomicsRisk FactorsRiversRoleSeverity of illnessSorting - Cell MovementSpleenSurfaceSystemTissuesTransgenic MiceUbiquitinUbiquitinationVertebratesViralViral Structural ProteinsViremiaVirionVirusWorkZika Virusacquired immunityantiviral immunitybasecell typechikungunyadiphtheria toxin receptorexperimental studyhuman diseaseimprovedin vivoinhibitorinnate immune mechanismsinsightmouse modelmutantnatural antibodiesnew therapeutic targetparticlereceptor bindingreverse geneticsscavenger receptortherapy developmenttransmission processuptakeviral RNAviral transmission
项目摘要
PROJECT SUMMARY
Arboviruses cause serious human disease. Viremia level following arbovirus infection of vertebrates is a critical
determinant of viral transmission cycles, global viral spread, and disease severity in individuals. Surprisingly, the
factors that dictate viremia following arbovirus infection are poorly defined. We found that multiple arboviruses,
including chikungunya (CHIKV), Ross River (RRV), o’nyong nyong (ONNV) and Zika viruses, are cleared from
the circulation by phagocytic cells. Experiments in splenectomized mice showed that the spleen is dispensable
for arboviral clearance. Instead, virus accumulates in the liver and clearance is independent of natural antibodies
and complement factors, suggesting a non-opsonic mechanism. Consistent with this idea, clearance of
circulating alphaviruses was blocked by competitive inhibitors of scavenger receptors (SRs) that mediate non-
opsonic uptake of non-self and modified-self ligands. Remarkably, we found that single lysine (K) to arginine (R)
mutations in the E2 glycoproteins of CHIKV and ONNV (E2 K200R), as well as RRV (E2 K251R), abrogated
clearance of circulating alphavirus particles by phagocytic cells, and promoted rapid viral dissemination to distal
tissues. Moreover, substitution of CHIKV E2 K200 with a variety of other amino acids also allows for clearance
evasion, suggesting a specific interaction between key K residues and a host factor. Ks are targets for post-
translational modification (PTM), and mass spectrometry analysis of E2 in virions revealed that CHIKV E2 K200
is ubiquitinated. These experiments have revealed a previously unrecognized pathway that controls arbovirus
viremia and dissemination in vertebrates. We hypothesize that PTM of key Ks in viral glycoproteins licenses the
capture of circulating arboviruses via SRs expressed on liver Kupffer cells (KCs). In Specific Aim 1, the cell
types that capture circulating arboviruses will be defined. We also will determine the role of KCs in viral clearance
and dissemination, and the development of anti-viral immunity. Finally, we will evaluate the role of phagocytic
cells, and KCs specifically, in the clearance of a genera-spanning panel of arboviruses. In Specific Aim 2, we
will define the spectrum of blood-borne arboviruses susceptible to SR-mediated clearance. We will use ELISA
and cellular binding assays to determine the murine and human SR(s) that bind virus particles. Using SR
knockout mice, we will determine the role of specific SRs in clearance of circulating arboviruses. In Specific Aim
3, we will define the role of E2 ubiquitination in the clearance of circulating CHIKV and RRV. We will use mass
spectrometry-based proteomics to determine K residues in arboviral particles that are modified with ubiquitin or
other PTMs. Finally, we will use a collection of reverse genetics systems to define the role of specific modified
Ks in arboviral clearance from the circulation. This work will provide new mechanistic understanding of arbovirus
clearance from the circulation. Elucidating these mechanisms could provide new insight into viral transmission,
dissemination, and pathogenesis, identify new risk factors of severe disease, and reveal new therapeutic targets
for the treatment of arboviral disease.
项目摘要
arbovirus会导致严重的人类疾病。脊椎动物arbovirus感染后的病毒血症水平是关键
病毒传播周期,全球病毒扩散和疾病严重程度的决定因素。令人惊讶的是,
arbovirus感染后决定病毒血症的因素的定义很差。我们发现多个arboviruse,
包括Chikungunya(Chikv),Ross River(RRV),O'Nyong Nyong(Onnv)和Zika病毒,从
吞噬细胞的循环。脾切除小鼠的实验表明脾脏是可分配的
用于arboviral清除。取而代之的是,病毒积聚在肝脏中,清除与天然抗体无关
和补体因素,提示非上官机制。与这个想法一致
循环α病毒被介导非 -
对非自身和改良自我配体的opsonic摄取。值得注意的是,我们发现单赖氨酸(K)到精氨酸(R)
CHIKV和ONNV(E2 K200R)的E2糖蛋白以及RRV(E2 K251R)的突变,废除
通过吞噬细胞清除循环α病毒颗粒,并促进了远端的快速病毒传播
组织。此外,用各种其他氨基酸替换Chikv E2 K200也可以清除
逃避,表明关键K残基与宿主因子之间存在特定的相互作用。 KS是后的目标
E2中E2的转化修饰(PTM)和质谱分析表明Chikv E2 K200
是泛素化的。这些实验揭示了一种先前无法识别的途径,可以控制Arbovirus
病毒血症和脊椎动物的传播。我们假设病毒糖蛋白中的关键KS的PTM许可
通过在肝脏库普弗细胞(KCS)上表达的SR捕获循环的arbovirus。在特定的目标1中,单元格
将定义捕获循环弧病毒的类型。我们还将确定KC在病毒清除中的作用
和传播,以及抗病毒免疫的发展。最后,我们将评估吞噬细胞的作用
细胞和KCS专门在清除跨孢病毒属属面板时。在特定的目标2中,我们
将定义易受SR介导的清除率的血传播arbovirus的频谱。我们将使用Elisa
和细胞结合测定,以确定结合病毒颗粒的鼠和人类SR。使用SR
敲除小鼠,我们将确定特定SR在清除循环弧病毒中的作用。在特定目标中
3,我们将定义E2泛素化在清除循环CHIKV和RRV中的作用。我们将使用质量
基于光谱法的蛋白质组学来确定用泛素或用泛素修饰或
其他PTM。最后,我们将使用反向遗传系统的集合来定义特定修改的作用
循环中的Arboviral清除中的KS。这项工作将提供对Arbovirus的新机械理解
循环清除。阐明这些机制可以为病毒传播提供新的见解,
传播和发病机理,识别严重疾病的新危险因素,并揭示了新的治疗靶标
用于治疗灰烬病毒疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas E Morrison其他文献
Thomas E Morrison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas E Morrison', 18)}}的其他基金
Mechanisms of immune suppression during arthritogenic alphavirus infections
致关节炎甲病毒感染期间的免疫抑制机制
- 批准号:
9294901 - 财政年份:2014
- 资助金额:
$ 46.55万 - 项目类别:
Mechanisms of immune suppression during arthritogenic alphavirus infections
致关节炎甲病毒感染期间的免疫抑制机制
- 批准号:
8757434 - 财政年份:2014
- 资助金额:
$ 46.55万 - 项目类别:
Mechanisms of immune suppression during arthritogenic alphavirus infections
致关节炎甲病毒感染期间的免疫抑制机制
- 批准号:
9097544 - 财政年份:2014
- 资助金额:
$ 46.55万 - 项目类别:
Persistent chikungunya virus infection and disease
持续的基孔肯雅病毒感染和疾病
- 批准号:
8177987 - 财政年份:2011
- 资助金额:
$ 46.55万 - 项目类别:
Persistent chikungunya virus infection and disease
持续的基孔肯雅病毒感染和疾病
- 批准号:
8268966 - 财政年份:2011
- 资助金额:
$ 46.55万 - 项目类别:
Pathogenesis of Arthritis and Myositis-Associated Alphaviruses
关节炎和肌炎相关甲病毒的发病机制
- 批准号:
7808916 - 财政年份:2009
- 资助金额:
$ 46.55万 - 项目类别:
Pathogenesis of Arthritis and Myositis-Associated Alphaviruses
关节炎和肌炎相关甲病毒的发病机制
- 批准号:
7512047 - 财政年份:2009
- 资助金额:
$ 46.55万 - 项目类别:
Pathogenesis of alphavirus-induced arthritis in mice.
甲病毒诱导的小鼠关节炎的发病机制。
- 批准号:
7068130 - 财政年份:2005
- 资助金额:
$ 46.55万 - 项目类别:
Pathogenesis of alphavirus-induced arthritis in mice.
甲病毒诱导的小鼠关节炎的发病机制。
- 批准号:
7227107 - 财政年份:2005
- 资助金额:
$ 46.55万 - 项目类别:
相似国自然基金
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:32202823
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
- 批准号:22105008
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
- 批准号:91953103
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:重大研究计划
相似海外基金
Impairment of B cell Responses by Pathogenic Chikungunya Viruses
致病性基孔肯雅病毒对 B 细胞反应的损害
- 批准号:
9753471 - 财政年份:2019
- 资助金额:
$ 46.55万 - 项目类别:
Impairment of B cell Responses by Pathogenic Chikungunya Viruses
致病性基孔肯雅病毒对 B 细胞反应的损害
- 批准号:
10540705 - 财政年份:2019
- 资助金额:
$ 46.55万 - 项目类别:
Impairment of B cell Responses by Pathogenic Chikungunya Viruses
致病性基孔肯雅病毒对 B 细胞反应的损害
- 批准号:
10310477 - 财政年份:2019
- 资助金额:
$ 46.55万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 46.55万 - 项目类别: